Warning letterFDA · Dec 20, 2023
Hua Da Trading, Inc. MARCS-CMS 664359, December 20, 2023
Named company: Hua Da Trading, Inc.
As described below, this product is an unapproved new drug sold in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 355(a) and 331(d). Furthermore,…
Lot information: not specified in this record.